Hyperbaric Oxygen Therapy (HBOT)

Hyperbaric oxygen therapy involves breathing 100% pure oxygen inside a pressurised chamber, dramatically increasing tissue oxygen saturation to stimulate stem cell mobilisation, reduce inflammation, and promote cellular regeneration.

Hyperbaric oxygen therapy (HBOT) is one of the most rigorously studied non-pharmacological longevity interventions available today. A landmark 2020 Tel Aviv University study demonstrated that a structured 60-session HBOT protocol produced measurable telomere lengthening of up to 38% and reduced senescent (zombie) cell burden by 37% in healthy older adults — two of the clearest biological markers of age reversal achieved in a clinical setting. During an HBOT session, clients breathe 100% medical-grade oxygen inside a pressurised hyperbaric chamber at 1.5 to 2.0 atmospheres absolute (ATA). Under these conditions, oxygen dissolves directly into plasma, cerebrospinal fluid, and lymphatic fluid — saturating tissues that red blood cells cannot easily reach under normal atmospheric pressure. This hyperoxic state triggers a cascade of regenerative responses including angiogenesis (new blood vessel formation), stem cell mobilisation from bone marrow, mitochondrial biogenesis, and downregulation of pro-inflammatory cytokines. At Lifespan Asia, HBOT referrals and protocols are coordinated to align with each client's longevity objectives and existing health picture. The standard longevity protocol involves 40 to 60 sessions delivered over two to three months, following the structure validated in published clinical research. For clients with specific targets — cognitive performance, athletic recovery, post-COVID neurological symptoms, or wound healing — the protocol is adapted accordingly. HBOT integrates powerfully with other longevity interventions available at the clinic. When combined with NAD+ infusions, the mitochondrial response to elevated oxygen is amplified, with clients frequently reporting sharper focus and improved sleep architecture. Safety is closely monitored, and clients with contraindications such as untreated pneumothorax are screened out during the initial consultation.